Builders Firstsource buy BiotechBee
Start price
03.09.23
/
70%
€138.35
Target price
30.11.25
€200.00
Performance (%)
-5.49%
End price
02.12.23
€130.75
Summary
This prediction ended on 02.12.23 with a price of €130.75. With a performance of -5.49%, the BUY prediction for Builders Firstsource by BiotechBee closed slightly in the red. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Builders Firstsource | -1.082% | -1.082% | -47.650% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % |
According to BiotechBee what are the pros and cons of Builders Firstsource for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Builders Firstsource diskutieren
Buy mit Kursziel 200,0